Literature DB >> 13639793

Reversal of tuberculin reaction in early tuberculosis.

J M ADAMS, V A KALAJAN, B O MORK, M ROSENBLATT, W J ROTHROCK, B J O'LOUGHLIN.   

Abstract

Entities:  

Keywords:  TUBERCULIN REACTION

Mesh：

Substances：

Year:  1959        PMID： 13639793     DOI： 10.1378/chest.35.4.348

Source DB:  PubMed          Journal:  Dis Chest        ISSN： 0096-0217


× No keyword cloud information.
  7 in total

1.  The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents.

Authors:  Jason R Andrews; Mark Hatherill; Hassan Mahomed; Willem A Hanekom; Monica Campo; Thomas R Hawn; Robin Wood; Thomas J Scriba
Journal:  Am J Respir Crit Care Med       Date:  2015-03-01       Impact factor: 21.405

2.  [Report on five cases of congenital tuberculosis. Possibility of achieving a sterilisatio magna by intensive and early therapy in one case of congenital tuberculosis by deglutition].

Authors:  C Daehler
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1969

3.  [On the question of the stability of the toxoplasmosis test].

Authors:  J Jíra; O Jírovec; V Bozdĕch
Journal:  Z Med Mikrobiol Immunol       Date:  1966-04-25

Review 4.  Tuberculosis vaccines and prevention of infection.

Authors:  Thomas R Hawn; Tracey A Day; Thomas J Scriba; Mark Hatherill; Willem A Hanekom; Thomas G Evans; Gavin J Churchyard; James G Kublin; Linda-Gail Bekker; Steven G Self
Journal:  Microbiol Mol Biol Rev       Date:  2014-12       Impact factor: 11.056

5.  Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease.

Authors:  Jon C Emery; Alexandra S Richards; Katie D Dale; C Finn McQuaid; Richard G White; Justin T Denholm; Rein M G J Houben
Journal:  Proc Biol Sci       Date:  2021-01-20       Impact factor: 5.349

6.  Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.

Authors:  Denise F Johnson; LaShaunda L Malone; Sarah Zalwango; Joy Mukisa Oketcho; Keith A Chervenak; Bonnie Thiel; Harriet Mayanja-Kizza; Catherine M Stein; W Henry Boom; Christina L Lancioni
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

7.  Mycobacterium tuberculosis-Specific T Cell Functional, Memory, and Activation Profiles in QuantiFERON-Reverters Are Consistent With Controlled Infection.

Authors:  Cheleka A M Mpande; Pia Steigler; Tessa Lloyd; Virginie Rozot; Boitumelo Mosito; Constance Schreuder; Timothy D Reid; Nicole Bilek; Morten Ruhwald; Jason R Andrews; Mark Hatherill; Francesca Little; Thomas J Scriba; Elisa Nemes
Journal:  Front Immunol       Date:  2021-08-30       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.